Startups & New Ventures

As a public research university, Rutgers also serves as a research hub for the Garden State and beyond, providing integrated support and resources for innovators and established or emerging companies seeking to advance critical R&D goals. Among these resources is Rutgers Core Services, offering specialized laboratories with state-of-the-art equipment, unique instrumentation and shared services managed by scientists with technical expertise and experience and available on a fee-for-service basis.

A Rutgers professor’s novel research into targeting and silencing defective, disease-causing RNA molecules has led to the launch of Ceptur Therapeutics, a startup that has raised $75 million in Series A funding.

The new I-Corps Northeast Hub, of which Rutgers, The State University of New Jersey is a key partner, announced its first researcher training program and is now accepting applications.

Asthma and allergies are chronic health conditions that continue to adversely impact the quality of life for many around the world. Thanks to exciting breakthroughs by Mark Siracusa, a researcher at Rutgers, The State University of New Jersey, there may be early signs of light at the end of the tunnel.

A group of former Rutgers students who developed a pacifier-like device that delivers medication and nutrients to malnourished infants are working to see their project put to use for the first time at a major hospital system.

It’s been a record year for innovation at Rutgers University, and for the Innovation Ventures team in the Office for Research, despite the challenges and new reality that came with the COVID-19 pandemic. Even limited access to laboratories, countless Zoom meetings, and the burnout many experienced over the past year could not stop the Rutgers Research and Innovation engine.